Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma
Titel:
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma
Auteur:
Bhamidipati, Pavan Kumar Fiala, Mark A. Grossman, Brenda J. DiPersio, John F. Stockerl-Goldstein, Keith Gao, Feng Uy, Geoffrey L. Westervelt, Peter Schroeder, Mark A. Cashen, Amanda F. Abboud, Camille N. Vij, Ravi
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 23 (2017) nr. 12 pagina's 2065-2069
Jaar:
2017
Inhoud:
Uitgever:
The American Society for Blood and Marrow Transplantation